MedPath

Class II Correction Study Using the Invisalign System

Not Applicable
Completed
Conditions
Malocclusion
Interventions
Device: Invisalign System
Registration Number
NCT02376829
Lead Sponsor
Align Technology, Inc.
Brief Summary

To demonstrate that growing teenagers which present up to full cusp Class II malocclusions can be treated using the Invisalign System.

Detailed Description

The Invisalignยฎ System consists of a series of clear plastic aligners that are intended to replace conventional wire and bracket technology for many orthodontic cases. Each custom manufactured aligner exerts gentle, continuous forces to move teeth incrementally from their original state to a final, treated state. Each aligner is worn for about two weeks, then replaced by the next in the series until the final position is achieved. For years, orthodontists and dentists have used removable appliances for orthodontic treatment. Today, with the application of computer technology and custom manufacturing, Invisalign treats a broader range of cases with greater precision.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
164
Inclusion Criteria
  • Subject must have fully erupted dentition excluding 2nd and 3rd molars
  • Age range 11-19 years old
  • Subject that requires bilateral Class II correction and must require at least 3mm of correction as measured by first molar relationship
Exclusion Criteria
  • Subject who has unerupted, erupting, partially erupted dentition (except for 2nd and 3rd molars)
  • Subject who has spaces between adjacent teeth larger than 3mm
  • Subject with active caries
  • Subject with periodontal disease
  • Subject does not have at least 1st molar fully captured in PVS (polyvinyl siloxane material ) impression or intraoral scan.
  • Subject with TMD (Temporomandibular joint dysfunction) symptoms
  • Subject has undergone pre-treatment with any orthodontic appliance (any previous treatment prior to study)
  • Subject has known allergy to latex and plastic
  • Subjects who are pregnant or will become pregnant during treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
The Invisalign SystemInvisalign SystemClass II correction of malocclusions
Primary Outcome Measures
NameTimeMethod
Rate of Tooth Movement at the End of Class II Correction.End of Class II Correction up to 18 months

The primary objective will be met through demonstrating that the velocity of Invisalign with MRF overjet correction is non-inferior to the published rates of Dynamax (0.42mm/month).

Secondary Outcome Measures
NameTimeMethod
Length of Treatment TimeEnd of Treatment approximately 2 years

This is the total treatment length of time that subjects took (in days) to complete Invisalign system treatment

Doctor Survey for Satisfaction With Treatment OutcomesEnd of Treatment approximately 2 years

Doctors filled out a Doctor Survey with a scale rating of 1 (very difficult) to 5 (very easy) on how easy the product was to use and their satisfaction with the product. A higher score on the scale meant a better satisfaction experience .

Patient Quality of Life Questionnaire Throughout TreatmentEnd of Treatment approximately 2 years

As part of the secondary objective, subject perception was assessed through analysis of case report forms. Case report form analysis of the Quality of Life forms was conducted from the subjects in both the Clinical Study and Continued Access Clinical Study. Subjects were asked to rate their orthodontic experience throughout the course of the study, with options 1(very difficult), 2 (difficult), 3 (average), 4 (easy), and 5 (very easy) as the ratings.

Trial Locations

Locations (10)

Dr. Mark Holt

๐Ÿ‡บ๐Ÿ‡ธ

Roseville, California, United States

Dr. Ray Kubisch and Dr. Drew Ferris

๐Ÿ‡บ๐Ÿ‡ธ

Santa Barbara, California, United States

Dr. William Kottemann

๐Ÿ‡บ๐Ÿ‡ธ

Maple Grove, Minnesota, United States

Dr. Donna Galante

๐Ÿ‡บ๐Ÿ‡ธ

Rocklin, California, United States

Dr. Barry Glaser

๐Ÿ‡บ๐Ÿ‡ธ

Cortlandt Manor, New York, United States

Dr. Sandra Selnick

๐Ÿ‡บ๐Ÿ‡ธ

Ellicott City, Maryland, United States

Dr. Gary Brigham

๐Ÿ‡บ๐Ÿ‡ธ

Scottsdale, Arizona, United States

Dr. Regina Blevins

๐Ÿ‡บ๐Ÿ‡ธ

Inver Grove Heights, Minnesota, United States

Dr. Sandra Tai

๐Ÿ‡จ๐Ÿ‡ฆ

Vancouver, British Columbia, Canada

Dr. Sam Daher

๐Ÿ‡จ๐Ÿ‡ฆ

Vancouver, British Columbia, Canada

ยฉ Copyright 2025. All Rights Reserved by MedPath